New York, NY, Sept. 18, 2013 (GLOBE NEWSWIRE) -- Good news continues to percolate for coffee drinkers. New research reveals that drinking four cups of coffee per day may help men reduce the risk of prostate cancer recurrence or spread by as much as 59 percent. The study provides further evidence of the health benefits of coffee consumption and its potential role in prostate cancer prevention.
The population study began with 1,000 men post-prostate cancer treatment and included analysis of their pre-diagnosis diet, lifestyle, and family history. Five and eight years later, the prostate cancer status and mortality of more than half of the participants were compared to pre-treatment coffee and tea intake. Dr. David Samadi, leading robotic prostate surgery expert and Chairman of Urology, Chief of Robotic Surgery at Lenox Hill Hospital, has long touted the health benefits of regular, moderate coffee consumption.
"Drinking coffee is as routine as brushing teeth for many of us," said Dr. Samadi. "While it's nice to hear the positive impact it can have on our health, it's most useful to understand the components of coffee that may help us prevent prostate cancer in the future."
Men who drank at least four cups of coffee per day, prior to their prostate cancer diagnosis, showed a 59 percent reduced risk of prostate cancer progression and/or recurrence compared to those who consumed just one or fewer cups per week. Researchers believe the bioactive compounds found in coffee are most beneficial, not the caffeine. The same benefits were not seen in participating tea drinkers.
Findings from the study, conducted at the Fred Hutchinson Cancer Research Center in Seattle, were published in the August issue of Cancer Causes and Control, http://rd.springer.com/article/10.1007%2Fs10552-013-0270-5.
"We're far from prescribing coffee to prevent prostate cancer or stave off recurrence," added Dr. Samadi. "But we do know that coffee contains both antioxidant and anti-inflammatory properties, both of which are proven cancer fighters. It appears there could be substantial benefit when those components accumulate in the body over time."
For now, Dr. Samadi and his team at the Lenox Hill Hospital Prostate Cancer Center will continue their dedication to life-saving robotic prostate surgery. Pairing state-of-the-art robotics with superior surgical expertise, Dr. Samadi has helped more than 5,000 patients achieve prostate cancer-free quality of life.
Lenox Hill Hospital and Dr. Samadi recently launched The Prostate Cancer Center Executive Suites where men and their families receive the highest level of prostate cancer expertise and luxury recovery accommodations. Designer-styled private and semi-private rooms include concierge-level amenities such as fine linens and towels, business necessities, chef-prepared meals and, of course, coffee.
Learn more at www.roboticoncology.com or by calling Dr. Samadi at 212-365-5000.
A photo accompanying this release is available at:
CONTACT: David B. Samadi, M.D Chairman of Urology, Chief of Robotic Surgery at Lenox Hill Hospital Tel: 1-212-365-5000 Fax: 1-646-692-6744 Address: 485 Madison Avenue 21st floor New York, NY 10022 http://www.roboticoncology.com/contact/